Generic placeholder image

Current Protein & Peptide Science

Editor-in-Chief

ISSN (Print): 1389-2037
ISSN (Online): 1875-5550

Research Article

Nucleotide-Binding Oligomerization Domain-Containing Protein 1 Regulates Inflammatory Response in Endometriosis

Author(s): Xin Wei, Yihua Liu, Weijia Li and Xu Shao*

Volume 23, Issue 2, 2022

Published on: 21 April, 2022

Page: [121 - 128] Pages: 8

DOI: 10.2174/1389203723666220322125031

Price: $65

Abstract

Background: Nucleotide-binding oligomerization domain-containing protein 1 (NOD1) is known to play an important role in innate immunity, while the relationship between NOD1 and inflammatory response in endometriosis remains unknown. The present study aims to investigate the effects of NOD1 on inflammatory response in endometriosis.

Methods: Immunohistochemistry staining, Western blot, and qRT-PCR were conducted to investigate the levels of NOD1 and inflammatory cytokines in the endometriotic lesions. A Spearman’s rank correlation analysis was conducted to determine the correlations of NOD1 and inflammatory cytokines (interleukin (IL)-6, tumor necrosis factor (TNF)-α, and monocyte chemoattractant protein (MCP)-1). Human endometrial stromal cells (HESCs) were isolated and incubated with peritoneal fluid with or without ML130. Cell viability was determined by using an MTT assay.

Results: A significant elevation in NOD1 and inflammatory cytokine was observed in ectopic endometrium. Interestingly, a positive correlation between NOD1 and inflammatory cytokines was observed. In addition, treatment with ML130 significantly suppressed cell viability and the production of inflammatory cytokines in the 20% peritoneal fluid treated ectopic HESCs.

Conclusions: NOD1 is related to the inflammatory response that is involved in endometriosis.

Keywords: Endometriosis, endometrial stromal cells, inflammation, NOD1, ML130, tumor necrosis factor.

Graphical Abstract

[1]
Stratton, P.; Berkley, K.J. Chronic pelvic pain and endometriosis: Translational evidence of the relationship and implications. Hum. Reprod. Update, 2011, 17(3), 327-346.
[http://dx.doi.org/10.1093/humupd/dmq050] [PMID: 21106492]
[2]
Vercellini, P.; Somigliana, E.; Viganò, P.; Abbiati, A.; Barbara, G.; Crosignani, P.G. Endometriosis: Current therapies and new pharmacological developments. Drugs, 2009, 69(6), 649-675.
[http://dx.doi.org/10.2165/00003495-200969060-00002] [PMID: 19405548]
[3]
Macer, M.L.; Taylor, H.S. Endometriosis and infertility: A review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet. Gynecol. Clin. North Am., 2012, 39(4), 535-549.
[http://dx.doi.org/10.1016/j.ogc.2012.10.002] [PMID: 23182559]
[4]
Bloski, T.; Pierson, R. Endometriosis and chronic pelvic pain: Unraveling the mystery behind this complex condition. Nurs. Womens. Health, 2008, 12(5), 382-395.
[http://dx.doi.org/10.1111/j.1751-486X.2008.00362.x] [PMID: 18837717]
[5]
Halis, G.; Arici, A. Endometriosis and inflammation in infertility. Ann. N. Y. Acad. Sci., 2004, 1034(1), 300-315.
[http://dx.doi.org/10.1196/annals.1335.032] [PMID: 15731321]
[6]
Jiang, L.; Yan, Y.; Liu, Z.; Wang, Y. Inflammation and endometriosis. Front. Biosci., 2016, 21(5), 941-948.
[http://dx.doi.org/10.2741/4431] [PMID: 27100482]
[7]
Wu, M-H.; Hsiao, K-Y.; Tsai, S-J. Endometriosis and possible inflammation markers. Gynecol. Minim. Invasive Ther., 2015, 4(3), 61-67.
[http://dx.doi.org/10.1016/j.gmit.2015.05.001]
[8]
Kajihara, H.; Yamada, Y.; Kanayama, S.; Furukawa, N.; Noguchi, T.; Haruta, S.; Yoshida, S.; Sado, T.; Oi, H.; Kobayashi, H. New insights into the pathophysiology of endometriosis: From chronic inflammation to danger signal. Gynecol. Endocrinol., 2011, 27(2), 73-79.
[http://dx.doi.org/10.3109/09513590.2010.507292] [PMID: 20712428]
[9]
Wu, M.Y.; Ho, H.N. The role of cytokines in endometriosis. Am. J. Reprod. Immunol., 2003, 49(5), 285-296.
[http://dx.doi.org/10.1034/j.1600-0897.2003.01207.x] [PMID: 12854733]
[10]
Tao, Y.; Zhang, Q.; Huang, W.; Zhu, H.; Zhang, D.; Luo, W. The peritoneal leptin, MCP-1 and TNF-α in the pathogenesis of endometriosis-associated infertility. Am. J. Reprod. Immunol., 2011, 65(4), 403-406.
[http://dx.doi.org/10.1111/j.1600-0897.2010.00920.x] [PMID: 20825374]
[11]
Chen, G.Y.; Shaw, M.H.; Redondo, G.; Núñez, G. The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis. Cancer Res., 2008, 68(24), 10060-10067.
[http://dx.doi.org/10.1158/0008-5472.CAN-08-2061] [PMID: 19074871]
[12]
Travassos, L.H.; Carneiro, L.A.; Girardin, S.E.; Boneca, I.G.; Lemos, R.; Bozza, M.T.; Domingues, R.C.; Coyle, A.J.; Bertin, J.; Philpott, D.J.; Plotkowski, M.C. Nod1 participates in the innate immune response to Pseudomonas aeruginosa. J. Biol. Chem., 2005, 280(44), 36714-36718.
[http://dx.doi.org/10.1074/jbc.M501649200] [PMID: 16150702]
[13]
da Silva Correia, J.; Miranda, Y.; Leonard, N.; Hsu, J.; Ulevitch, R.J. Regulation of Nod1-mediated signaling pathways. Cell Death Differ., 2007, 14(4), 830-839.
[http://dx.doi.org/10.1038/sj.cdd.4402070] [PMID: 17186025]
[14]
Zhao, L.; Hu, P.; Zhou, Y.; Purohit, J.; Hwang, D. NOD1 activation induces proinflammatory gene expression and insulin resistance in 3T3-L1 adipocytes. Am. J. Physiol. Endocrinol. Metab., 2011, 301(4), E587-E598.
[http://dx.doi.org/10.1152/ajpendo.00709.2010] [PMID: 21693690]
[15]
Moreira, L.O.; Zamboni, D.S. NOD1 and NOD2 signaling in infection and inflammation. Front. Immunol., 2012, 3, 328.
[http://dx.doi.org/10.3389/fimmu.2012.00328] [PMID: 23162548]
[16]
Mukherjee, T.; Hovingh, E.S.; Foerster, E.G.; Abdel-Nour, M.; Philpott, D.J.; Girardin, S.E. NOD1 and NOD2 in inflammation, immunity and disease. Arch. Biochem. Biophys., 2019, 670, 69-81.
[http://dx.doi.org/10.1016/j.abb.2018.12.022] [PMID: 30578751]
[17]
Kajihara, T.; Tanaka, K.; Oguro, T.; Tochigi, H.; Prechapanich, J.; Uchino, S.; Itakura, A.; Sućurović, S.; Murakami, K.; Brosens, J.J.; Ishihara, O. Androgens modulate the morphological characteristics of human endometrial stromal cells decidualized in vitro. Reprod. Sci., 2014, 21(3), 372-380.
[http://dx.doi.org/10.1177/1933719113497280] [PMID: 23885104]
[18]
Liu, H.; Zhang, Z.; Xiong, W.; Zhang, L.; Xiong, Y.; Li, N.; He, H.; Du, Y.; Liu, Y. Hypoxia-inducible factor-1α promotes endometrial stromal cells migration and invasion by upregulating autophagy in endometriosis. Reproduction, 2017, 153(6), 809-820.
[http://dx.doi.org/10.1530/REP-16-0643] [PMID: 28348069]
[19]
Strober, W.; Murray, P.J.; Kitani, A.; Watanabe, T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat. Rev. Immunol., 2006, 6(1), 9-20.
[http://dx.doi.org/10.1038/nri1747] [PMID: 16493424]
[20]
King, A.E.; Horne, A.W.; Hombach-Klonisch, S.; Mason, J.I.; Critchley, H.O. Differential expression and regulation of nuclear oligomerization domain proteins NOD1 and NOD2 in human endometrium: A potential role in innate immune protection and menstruation. Mol. Hum. Reprod., 2009, 15(5), 311-319.
[http://dx.doi.org/10.1093/molehr/gap020] [PMID: 19273470]
[21]
Wu, Y.; Kajdacsy-Balla, A.; Strawn, E.; Basir, Z.; Halverson, G.; Jailwala, P.; Wang, Y.; Wang, X.; Ghosh, S.; Guo, S.W. Transcriptional characterizations of differences between eutopic and ectopic endometrium. Endocrinology, 2006, 147(1), 232-246.
[http://dx.doi.org/10.1210/en.2005-0426] [PMID: 16195411]
[22]
Chegini, N.; Roberts, M.; Ripps, B. Differential expression of interleukins (IL)-13 and IL-15 in ectopic and eutopic endometrium of women with endometriosis and normal fertile women. Am. J. Reprod. Immunol., 2003, 49(2), 75-83.
[http://dx.doi.org/10.1034/j.1600-0897.2003.00028.x] [PMID: 12765345]
[23]
Ryan, I.P.; Tseng, J.F.; Schriock, E.D.; Khorram, O.; Landers, D.V.; Taylor, R.N. Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis. Fertil. Steril., 1995, 63(4), 929-932.
[http://dx.doi.org/10.1016/S0015-0282(16)57506-2] [PMID: 7890085]
[24]
Symons, L.K.; Miller, J.E.; Kay, V.R.; Marks, R.M.; Liblik, K.; Koti, M.; Tayade, C. The immunopathophysiology of endometriosis. Trends Mol. Med., 2018, 24(9), 748-762.
[http://dx.doi.org/10.1016/j.molmed.2018.07.004] [PMID: 30054239]
[25]
Herington, J.L.; Bruner-Tran, K.L.; Lucas, J.A.; Osteen, K.G. Immune interactions in endometriosis. Expert Rev. Clin. Immunol., 2011, 7(5), 611-626.
[http://dx.doi.org/10.1586/eci.11.53] [PMID: 21895474]
[26]
Sun, W.; Liu, C.; Zhang, Y.; Qiu, X.; Zhang, L.; Zhao, H.; Rong, Y.; Sun, Y. Ilexgenin A, a novel pentacyclic triterpenoid extracted from Aquifoliaceae shows reduction of LPS-induced peritonitis in mice. Eur. J. Pharmacol., 2017, 797, 94-105.
[http://dx.doi.org/10.1016/j.ejphar.2017.01.019] [PMID: 28104349]
[27]
Lousse, J-C.; Van Langendonckt, A.; Defrere, S.; Ramos, R.G.; Colette, S.; Donnez, J. Peritoneal endometriosis is an inflammatory disease. Front. Biosci. (Elite Ed.), 2012, 4(1), 23-40.
[http://dx.doi.org/10.2741/e358] [PMID: 22201853]
[28]
Delbandi, A-A.; Mahmoudi, M.; Shervin, A.; Heidari, S.; Kolahdouz-Mohammadi, R.; Zarnani, A-H. Evaluation of apoptosis and angiogenesis in ectopic and eutopic stromal cells of patients with endometriosis compared to non-endometriotic controls. BMC Womens Health, 2020, 20(1), 3.
[http://dx.doi.org/10.1186/s12905-019-0865-4] [PMID: 31906916]
[29]
Liu, C.; Zhao, J.; Liu, Y.; Huang, Y.; Shen, Y.; Wang, J.; Sun, W.; Sun, Y. A novel pentacyclic triterpenoid, Ilexgenin A, shows reduction of atherosclerosis in apolipoprotein E deficient mice. Int. Immunopharmacol., 2016, 40, 115-124.
[http://dx.doi.org/10.1016/j.intimp.2016.08.024] [PMID: 27588911]
[30]
Arici, A.; MacDonald, P.C.; Casey, M.L. Regulation of monocyte chemotactic protein-1 gene expression in human endometrial cells in cultures. Mol. Cell. Endocrinol., 1995, 107(2), 189-197.
[http://dx.doi.org/10.1016/0303-7207(94)03442-V] [PMID: 7768330]
[31]
Wingfield, M.; Macpherson, A.; Healy, D.L.; Rogers, P.A. Cell proliferation is increased in the endometrium of women with endometriosis. Fertil. Steril., 1995, 64(2), 340-346.
[http://dx.doi.org/10.1016/S0015-0282(16)57733-4] [PMID: 7542208]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy